Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report

  • Vallari Shah1Email author,
  • Kevin D. Boyd2,
  • Richard S. Houlston1, 3 and
  • Martin F. Kaiser1
BMC Cancer201717:718

https://doi.org/10.1186/s12885-017-3715-5

Received: 27 June 2017

Accepted: 30 October 2017

Published: 6 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Jun 2017 Submitted Original manuscript
14 Jul 2017 Reviewed Reviewer Report - Sabarinath Venniyil Radhakrishna
17 Jul 2017 Reviewed Reviewer Report - Douglas Sborov
15 Aug 2017 Author responded Author comments - Vallari Shah
Resubmission - Version 2
15 Aug 2017 Submitted Manuscript version 2
8 Sep 2017 Reviewed Reviewer Report - Sabarinath Venniyil Radhakrishna
21 Oct 2017 Author responded Author comments - Vallari Shah
Resubmission - Version 3
21 Oct 2017 Submitted Manuscript version 3
Publishing
30 Oct 2017 Editorially accepted
6 Nov 2017 Article published 10.1186/s12885-017-3715-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Molecular Pathology, The Institute of Cancer Research
(2)
Department of Haemato-Oncology, Royal Marsden Hospital
(3)
Division of Genetics and Epidemiology, The Institute of Cancer Research

Advertisement